{"organizations": [], "uuid": "b44642ab9adb41e1c5272eafee394036dc9e2a2a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-teva-pharmaceutical-industries-fil/brief-teva-pharmaceutical-industries-files-for-offering-of-up-to-5-0-bln-of-debt-securities-purchase-contracts-and-units-idUSFWN1PO196", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Pharmaceutical Industries Files For Offering Of Up To $5.0 Bln Of Debt Securities, Purchase Contracts And Units", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T01:07:00.000+02:00", "replies_count": 0, "uuid": "b44642ab9adb41e1c5272eafee394036dc9e2a2a"}, "author": "", "url": "https://www.reuters.com/article/brief-teva-pharmaceutical-industries-fil/brief-teva-pharmaceutical-industries-files-for-offering-of-up-to-5-0-bln-of-debt-securities-purchase-contracts-and-units-idUSFWN1PO196", "ord_in_thread": 0, "title": "BRIEF-Teva Pharmaceutical Industries Files For Offering Of Up To $5.0 Bln Of Debt Securities, Purchase Contracts And Units", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-teva pharmaceutical industries", "sentiment": "negative"}, {"name": "bln of debt securities", "sentiment": "negative"}, {"name": "brief-teva pharmaceutical industri", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "teva", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 29 (Reuters) - Teva Pharmaceutical Industries Ltd :\n* TEVA PHARMACEUTICAL INDUSTRIES LIMITED FILES FOR OFFERING OF UP TO $5.0 BILLION OF DEBT SECURITIES, PURCHASE CONTRACTS AND UNITS - SEC FILING Source text: ( bit.ly/2DJPFkq ) Further company coverage:\n ", "external_links": [], "published": "2018-01-30T01:07:00.000+02:00", "crawled": "2018-01-30T01:24:49.009+02:00", "highlightTitle": ""}